Eli Lilly & Co. vs. Viatris Inc. Common Stock
Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| LLY | VTRS | |
|---|---|---|
| Market Cap | $1.09 trillion | $18.49 billion |
| Revenue (TTM) | — | $14.74 billion |
| Net Income (TTM) | — | $-410,700,000 |
LLY leads on 1 of 1 size & scale factors.
Valuation
| LLY | VTRS | |
|---|---|---|
| Price / Book | — | 1.30 |
| Price / Sales | — | 1.25 |
LLY and VTRS split the valuation factors evenly.
Profitability
| LLY | VTRS | |
|---|---|---|
| Net Margin | — | -2.79% |
| Return on Equity | — | -2.88% |
LLY and VTRS split the profitability factors evenly.
Dividend
| LLY | VTRS | |
|---|---|---|
| Dividend Yield | — | 2.96% |
LLY and VTRS split the dividend factors evenly.
Risk & Sentiment
| LLY | VTRS | |
|---|---|---|
| Short Interest | 1.29% | 4.03% |
LLY leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, VTRS overview, VTRS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.